SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-318386
Filing Date
2018-11-05
Accepted
2018-11-05 16:16:05
Documents
3
Period of Report
2018-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d650466d8k.htm 8-K 14691
2 EX-99.1 d650466dex991.htm EX-99.1 97329
3 GRAPHIC g650466g84a92.jpg GRAPHIC 5919
  Complete submission text file 0001193125-18-318386.txt   121449
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 181160098
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1